Chemoinformaics analysis of 4-METHOXYBENZOIC-ACID
| Molecular Weight | 152.149 | nRot | 2 |
| Heavy Atom Molecular Weight | 144.085 | nRig | 7 |
| Exact Molecular Weight | 152.047 | nRing | 1 |
| Solubility: LogS | -2.324 | nHRing | 0 |
| Solubility: LogP | 2.047 | No. of Aliphatic Rings | 0 |
| Acid Count | 1 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 19 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 11 | No. of Aromatic Carbocycles | 1 |
| nHetero | 3 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 8 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 8 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 3 | No. of Arom Bond | 6 |
| nHA | 2 | APOL | 21.1003 |
| nHD | 1 | BPOL | 10.6297 |
| QED | 0.696 |
| Synth | 1.171 |
| Natural Product Likeliness | -0.173 |
| NR-PPAR-gamma | 0.003 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0 |
| Pgp-sub | 0.001 |
| HIA | 0.006 |
| CACO-2 | -4.831 |
| MDCK | 0.0000109 |
| BBB | 0.475 |
| PPB | 0.639303 |
| VDSS | 0.226 |
| FU | 0.261456 |
| CYP1A2-inh | 0.069 |
| CYP1A2-sub | 0.722 |
| CYP2c19-inh | 0.068 |
| CYP2c19-sub | 0.057 |
| CYP2c9-inh | 0.037 |
| CYP2c9-sub | 0.288 |
| CYP2d6-inh | 0.019 |
| CYP2d6-sub | 0.125 |
| CYP3a4-inh | 0.029 |
| CYP3a4-sub | 0.111 |
| CL | 5.227 |
| T12 | 0.897 |
| hERG | 0.083 |
| Ames | 0.008 |
| ROA | 0.206 |
| SkinSen | 0.166 |
| Carcinogencity | 0.107 |
| EI | 0.992 |
| Respiratory | 0.16 |
| NR-Aromatase | 0.004 |
| Antiviral | No |
| Prediction | 0.851355 |